Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Scientific Reports|February 13, 2015
The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatmentHongde Li, Wandi Zhu, Leike Zhang, et al.
ACS Nano|July 1, 2025
Mature Dendritic Cell-Derived Extracellular Vesicles are Potent Mucosal Adjuvants for Influenza Hemagglutinin VaccinesChunhong Dong, Lai Wei, Wandi Zhu, et al.
ACS Applied Materials & Interfaces|January 27, 2022
Polycationic HA/CpG Nanoparticles Induce Cross-Protective Influenza Immunity in MiceChunhong Dong, Ye Wang, Wandi Zhu, et al.
JCI Insight|June 22, 2021
Modulation of the effects of class Ib antiarrhythmics on cardiac NaV1.5-encoded channels by accessory NaVβ subunitsWandi Zhu, Wei Wang, Paweorn Angsutararux, et al.
Vaccine|December 28, 2024
Impact of influenza immune imprinting on immune responses to subsequent vaccinations in miceYao Ma, Chunhong Dong, Joo Kyung Kim, et al.
Journal of Molecular and Cellular Cardiology|January 24, 2016
A novel NaV1.5 voltage sensor mutation associated with severe atrial and ventricular arrhythmiasHong-Gang Wang, Wandi Zhu, Ronald J Kanter, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 24, 2017
A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccinesWandi Zhu, Winston Pewin, Chao Wang, et al.
Nanoscale Horizons|September 6, 2024
Double-layered protein nanoparticles conjugated with truncated flagellin induce improved mucosal and systemic immune responses in miceJoo Kyung Kim, Wandi Zhu, Chunhong Dong, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 7, 2021
Influenza NP core and HA or M2e shell double-layered protein nanoparticles induce broad protection against divergent influenza A virusesYao Ma, Ye Wang, Chunhong Dong, et al.
Journal of Innate Immunity|July 23, 2013
Interferon-induced proteins with tetratricopeptide repeats 1 and 2 are cellular factors that limit hepatitis B virus replicationRongjuan Pei, Bo Qin, Xiaoyong Zhang, et al.
Pageof 7